Pulmonary Embolism
📧 Sign up to get email alerts when something new happens for Pulmonary Embolism.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2009-06-17Clinical Trial Update: Adjuvant Treatment of Pulmonary Embolism With Drotrecogin Alfa (Activated): Phase II Exploratory Study [Phase 2]
Phase II exploratory trial evaluating adjuvant treatment of submassive pulmonary embolism with drotrecogin alfa activated; the study has com…
-
CLINICAL_TRIALS trial_result · 2009-04-29Clinical Trial Update: SR34006 Compared to Vitamin K Antagonist (VKA) in the Treatment of Pulmonary Embolism [Phase 3]
A Phase 3 trial comparing SR34006 to a vitamin K antagonist for the treatment of pulmonary embolism has completed.
-
CLINICAL_TRIALS trial_result · 2009-04-14Clinical Trial Update: A Phase II Study to Evaluate the Efficacy of ThromboView® in the Detection of Pulmonary Emboli [Phase 2]
This document reports the completion of a Phase II study evaluating ThromboView for detecting pulmonary emboli.
-
CLINICAL_TRIALS trial_result · 2009-03-31Clinical Trial Update: Home Treatment of Patients With Pulmonary Embolism Based on Pro-Brain Natriuretic Peptide (BNP) Levels [NA]
A completed study evaluated home treatment of pulmonary embolism guided by pro-brain natriuretic peptide (BNP) levels.
-
CLINICAL_TRIALS trial_result · 2009-02-13Clinical Trial Update: Tinzaparin in the Treatment of the Acute Pulmonary Embolism [Phase 4]
A Phase 4 clinical trial evaluating tinzaparin for acute pulmonary embolism has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2009-02-05Clinical Trial Update: Strategies for Suspected Pulmonary Embolism in Emergency Departments [NA]
A completed clinical trial update from University Hospital Angers about strategies for evaluating and managing patients with suspected pulmo…
-
CLINICAL_TRIALS trial_result · 2009-02-04Clinical Trial Update: Fondaparinux as Monotherapy for DVT and/or Pulmonary Embolism [NA]
Clinical trial completed evaluating fondaparinux as monotherapy for deep vein thrombosis and pulmonary embolism.
-
CLINICAL_TRIALS trial_result · 2009-02-02Clinical Trial Update: Multi-Center Human Alert Trial to Prevent DVT and PE
A multi-center trial aimed at preventing deep vein thrombosis and pulmonary embolism has completed, with results now available.
-
CLINICAL_TRIALS research · 2009-01-21Clinical Trial Update: Risk Factors for Venous Thromboembolism
A completed clinical trial update examining risk factors for venous thromboembolism, including deep vein thrombosis and pulmonary embolism.
-
CLINICAL_TRIALS trial_result · 2008-12-01Clinical Trial Update: 12-h and 2-h Urokinase Regimes of Pulmonary Thromboembolism in China [Phase 4]
Phase 4 clinical trial comparing 12-hour and 2-hour urokinase regimens for pulmonary embolism in China has completed.
-
CLINICAL_TRIALS trial_result · 2008-11-24Clinical Trial Update: Nadroparin for the Initial Treatment of Pulmonary Thromboembolism [Phase 4]
A Phase 4 trial evaluating nadroparin for the initial treatment of pulmonary embolism has completed.
-
CLINICAL_TRIALS trial_result · 2008-10-29Clinical Trial Update: Low Dosage of rt-PA in the Treatment of Pulmonary Thromboembolism in China [Phase 4]
Phase 4 clinical trial in China evaluating low-dose rt-PA for pulmonary embolism has completed.
-
FDA approval · 2008-10-17FDA Approved: DRAXIMAGE MAA — Supplemental Application (Jubilant DraxImage Inc)
FDA approved a supplemental application for the DRAXIMAGE MAA kit to prepare Tc-99m-labeled albumin aggregates for lung perfusion imaging to…
-
FDA approval · 2008-10-17FDA Approved: ARIXTRA — Supplemental Application (Mylan Institutional LLC)
The FDA approved a supplemental application for ARIXTRA (fondaparinux sodium) filed by Mylan Institutional LLC. The approval updates the exi…
-
CLINICAL_TRIALS research · 2008-08-21Clinical Trial Update: A Pharmacogenetic Study of Warfarin Dosing, "The COUMA-GEN Study" [NA]
This completed clinical trial evaluated pharmacogenetic factors affecting warfarin dosing in patients with atrial fibrillation, deep vein th…
-
CLINICAL_TRIALS trial_result · 2008-08-05Clinical Trial Update: Protection From Pulmonary Embolism With the Permanent OptEase™ Filter (PROOF) [Phase 4]
Phase 4 clinical trial update evaluating protection from pulmonary embolism with the OptEase permanent filter; the study has completed.
-
CLINICAL_TRIALS trial_result · 2008-05-16Clinical Trial Update: Investigation Into the Therapeutic Dosage of Fondaparinux Sodium, a Medication Used to Prevent Blood Clots in Morbidly Obese Volunteers [Phase 2]
Phase 2 clinical trial completed evaluating the therapeutic dosage of fondaparinux sodium to prevent blood clots in morbidly obese volunteer…
-
EMA withdrawal · 2008-05-16EMA Withdrawn: Quixidar (fondaparinux sodium) — Glaxo Group Ltd.
The EMA indicates withdrawal of Quixidar (fondaparinux sodium) from the market by Glaxo Group Ltd., covering indications including venous th…
-
CLINICAL_TRIALS trial_result · 2008-05-06Clinical Trial Update: Tenecteplase Pulmonary Embolism Italian Study [Phase 2]
Phase 2 Italian study evaluating tenecteplase for pulmonary embolism has been terminated.
-
CLINICAL_TRIALS trial_result · 2008-03-31Clinical Trial Update: New Oral Anticoagulant Therapy for the Prevention of Blood Clots Following Hip or Knee Replacement Surgery [Phase 2]
Phase 2 trial evaluating a new oral anticoagulant to prevent venous thromboembolism after total hip or total knee replacement has completed.
-
FDA approval · 2008-03-28FDA Approved: JANTOVEN — Supplemental Application (Upsher-Smith Laboratories, LLC)
The FDA approved a supplemental application for Jantoven (warfarin sodium) filed by Upsher-Smith Laboratories, LLC.
-
CLINICAL_TRIALS trial_result · 2008-03-11Clinical Trial Update: Venous Blood Flow Velocity: Electrical Foot Stimulation Compared to Intermittent Pneumatic Compression of the Foot [Phase 1]
Phase 1 clinical trial comparing electrical foot stimulation with intermittent pneumatic compression to improve venous blood flow in deep ve…
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Treatment for Blood Clots in the Veins of the Legs [Phase 1]
A Phase 1 study evaluating a treatment for blood clots in leg veins has completed. Conditions include deep vein thrombosis, pulmonary emboli…
-
CLINICAL_TRIALS trial_result · 2008-01-07Clinical Trial Update: Detection of Pulmonary Embolism With CECT [Phase 4]
Phase 4 trial assessing detection of pulmonary embolism using contrast-enhanced CT has completed.
-
FDA approval · 2007-12-14FDA Approved: HEPARIN SODIUM — Supplemental Application (Civica, Inc.)
FDA approved Civica, Inc.'s supplemental application for HEPARIN SODIUM. This action approves a supplemental NDA related to the product (NDA…